Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion

2 years ago

LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a…

Revolutionizing Regtech: LighthouseAI Secures Strategic Investment and Landmark Law Firm Partnership

2 years ago

LighthouseAI Set to Impact the Regulatory Technology Industry with AI-driven ComplianceLOS ANGELES, CA / ACCESSWIRE / November 16, 2023 /…

REMORY, a Supplement Known for Containing Plasmalogens, Which Are Recognized for Their Role in Preventing Cognitive Decline, Now Available in the United States

2 years ago

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and…

Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company’s inaugural globalization venture

2 years ago

NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Pharmaceutical 3D screen printing company Laxxon Medical has been selected…

NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan

2 years ago

NLS has executed a non-binding term sheet for licensing of NLS intellectual propertyNLS has secured an additional bridge loan through…

Harbour Coca Approved to Commercially Distribute Coca Leaf Internationally Following Landmark Trade Agreement with Peruvian State-Run Coca Leaf Producer

2 years ago

Harbour Becomes Authorized Agent of Coca Globally, Permitting the Distribution of Ethically Sourced, High-Quality Coca Leaf For Emerging OpportunitiesToronto, Ontario--(Newsfile…

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

2 years ago

Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…

Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS

2 years ago

POLB 001 - a potential blockbuster immunomodulatorLONDON, UK / ACCESSWIRE / November 16, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or…

PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update

2 years ago

TARRYTOWN, NY / ACCESSWIRE / November 15, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for…